C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 417/04 (2006.01) A61K 31/41 (2006.01) A61K 31/435 (2006.01) A61K 31/495 (2006.01) A61P 3/04 (2006.01) A61P 3/06 (2006.01) A61P 3/10 (2006.01) C07D 263/58 (2006.01) C07D 277/68 (2006.01) C07D 277/82 (2006.01) C07D 413/04 (2006.01) C07D 413/12 (2006.01) C07D 417/14 (2006.01)
Patent
CA 2589678
The present invention relates to a melanin concentrating hormone antagonist compound of formula (I); wherein Ar1, L1, R1, q, X, R2, R3, R4, and R5 are as defined, or a pharmaceutically acceptable salt, solvate, or enantiomer thereof useful in the treatment, prevention or amelioration of symptoms associated with obesity and related diseases.
L'invention concerne un composé antagoniste de l'hormone concentrant la mélanine (MCH) représenté par la formule (I), ou un sel, un solvate ou un énantiomère acceptable sur le plan pharmaceutique de ce composé, utile dans le traitement, la prévention et le soulagement des symptômes associés à l'obésité ou à des maladies connexes. Dans la formule (I), Ar1, L1, R1, q, X, R2, R3, R4, et R5 sont tel que définis dans la description.
Beck James Peter
Cordier Frederic Laurent
Dominguez-Manzanares Esteban
Gardinier Kevin Matthew
Greenen Peter Michael
Eli Lilly And Company
Gowling Lafleur Henderson Llp
LandOfFree
Novel mch receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel mch receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel mch receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1410850